Finance

Beta
Lists
UNCY:NASDAQ
Unicycive Therapeutics Inc
$6.92
-6.86%
(-0.51) 1D
$7.06
+2.02% (+0.14)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNCY...
Open
$7.41
High
$7.41
Low
$6.86
Mkt. cap
184.76M
Avg. vol.
642.17K
Volume
1.20M
52-wk high
$11.00
52-wk low
$3.72
EPS
-$2.08
Beta
1.73
Shares outstanding
26.70M
No. of employees
22
Open
$7.41
High
$7.41
Low
$6.86
Mkt. cap
184.76M
Avg. vol.
642.17K
Volume
1.20M
52-wk high
$11.00
52-wk low
$3.72
EPS
-$2.08
Beta
1.73
Shares outstanding
26.70M
No. of employees
22
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to UNCY in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for UNCY in the last 3 months.
Highest
Current $6.92
$90.00 (+1,200.58%)
Average
$41.50 (+499.71%)
Lowest
$18.00 (+160.12%)
News stories
From sources across the web
About Unicycive Therapeutics Inc
CEO-
Employees22
Founded2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.75M
2.96M
2.25M
1.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.21M
4.38M
4.97M
6.83M
Operating expense
6.96M
7.34M
7.22M
8.44M
Total operating expenses
6.96M
7.34M
7.22M
8.44M
Operating income
-6.96M
-7.34M
-7.22M
-8.44M
Other non operating income
374.00K
1.07M
-7.77M
-4.78M
EBT including unusual items
-6.45M
-6.01M
-14.67M
-12.82M
EBT excluding unusual items
-6.45M
-6.01M
-14.67M
-12.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.45M
-6.01M
-14.67M
-12.82M
Net profit margin
-
-
-
-
Earnings per share
-0.52
-0.33
-0.82
-0.54
Interest and investment income
155.00K
279.00K
351.00K
394.00K
Interest expense
-13.00K
-15.00K
-27.00K
-
Net interest expenses
142.00K
264.00K
324.00K
394.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.96M
-7.33M
-7.21M
-8.43M
Gain or loss from assets sale
-
-
-
18.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more